Loading…
Based on limited metadata, the FDA issued a Warning Letter to Lantech Pharmaceuticals Limited, a drug manufacturer, on August 8, 2019. While the specific violations are not detailed in the available metadata, the letter indicates regulatory concerns with the company's drug manufacturing or compliance practices. Without access to the full letter text or specific violation details, the exact nature of the deficiencies cannot be determined, though they fall under FDA's drug product oversight authority.